[1]
“Determining the directions for developing a methodology for comprehensive assessment of ESG activity in China’s biopharmaceutical territorial-sectoral complexes”, meps, vol. 12, pp. 61–74, Dec. 2025, doi: 10.17308/meps/2078-9017/2025/12/61-74.